Wednesday November 25 2009 | Biotechnology feed | All feeds

News Articles on Dailyupdates

Emerging oncology treatments: A focus on targeted therapeutics,

http://www.bioportfolio.com/news/Emerging_oncology_treatments%3A_A_focus_on_targeted.html - Thursday June 1 2006

COX-2 withdrawal - Therapeutic, R&D and pharmaceutical impact

http://www.bioportfolio.com/news/COX-2_withdrawal_-_Therapeutic%2C_R%26amp%3BD_and.html - Friday October 1 2004

SOCS1 silencing dramatically increases the anti-cancer efficacy of

http://www.bioportfolio.com/news/SOCS1_silencing_dramatically_increases_the.html - Tuesday June 1 2004

Gabapentin as a first line treatment of spinal cord injury-related

http://www.bioportfolio.com/news/Gabapentin_as_a_first_line_treatment_of_spinal.html - Saturday May 1 2004

Results from the PACES trials provides further good news for Pfizer's

http://www.bioportfolio.com/news/Results_from_the_PACES_trials_provides_further.html - Saturday May 1 2004

NicOx's nitro-derivative of naproxen, HCT 3012, shown to be effective in

http://www.bioportfolio.com/news/NicOx%27s_nitro-derivative_of_naproxen%2C_HCT_3012%2C.html - Saturday May 1 2004

Lilly's pemetrexed (Alimta) offers potential improvements in the

http://www.bioportfolio.com/news/Lilly%27s_pemetrexed_%28Alimta%29_offers_potential.html - Saturday May 1 2004

HIV infection - changes in epidemiology driving R&D development and

http://www.bioportfolio.com/news/HIV_infection_-_changes_in_epidemiology_driving.html - Saturday May 1 2004

GREES publish new recommendations on the clinical development of disease

http://www.bioportfolio.com/news/GREES_publish_new_recommendations_on_the_clinical.html - Thursday April 1 2004

New data shows that intensive treatment of diabetes may lower coexistent

http://www.bioportfolio.com/news/New_data_shows_that_intensive_treatment_of.html - Thursday April 1 2004

Eli Lilly's Duloxetine set to become the first widely used therapeutic

http://www.bioportfolio.com/news/Eli_Lilly%27s_Duloxetine_set_to_become_the_first.html - Thursday April 1 2004

Gene silence to set to quieten neuropathic pain - Novartis research

http://www.bioportfolio.com/news/Gene_silence_to_set_to_quieten_neuropathic_pain_-.html - Thursday April 1 2004

NicOx's nitrosulindac (NCX 1102) emerges as a candidate treatment of

http://www.bioportfolio.com/news/NicOx%27s_nitrosulindac_%28NCX_1102%29_emerges_as_a.html - Thursday April 1 2004

Drug delivery technology predicted to allow safer and more effective use

http://www.bioportfolio.com/news/Drug_delivery_technology_predicted_to_allow_safer.html - Thursday April 1 2004

HU-320 identified as a novel synthetic cannabinoid with therapeutic

http://www.bioportfolio.com/news/HU-320_identified_as_a_novel_synthetic.html - Thursday April 1 2004

Merckle demonstrate superior safety of Licofelone the first dual COX/LOX

http://www.bioportfolio.com/news/Merckle_demonstrate_superior_safety_of_Licofelone.html - Thursday April 1 2004

New data reveals that the calcium channel blocker ethosuximide is an

http://www.bioportfolio.com/news/New_data_reveals_that_the_calcium_channel_blocker.html - Thursday April 1 2004

New data confirm that Fujisawa Pharmaceuticals' poly (ADP-ribose)

http://www.bioportfolio.com/news/New_data_confirm_that_Fujisawa_Pharmaceuticals%27.html - Monday March 1 2004

Overexpression of malonyl-coenzyme A (CoA) decarboxylase as a novel

http://www.bioportfolio.com/news/Overexpression_of_malonyl-coenzyme_A_%28CoA%29.html - Monday March 1 2004

Yale researchers discover a role for Kv1.3 potassium channels in the

http://www.bioportfolio.com/news/Yale_researchers_discover_a_role_for_Kv1.3.html - Monday March 1 2004

Granulocyte colony-stimulating factor (G-CSF) as a new therapeutic

http://www.bioportfolio.com/news/Granulocyte_colony-stimulating_factor_%28G-CSF%29_as.html - Monday March 1 2004

Potential of ghrelin receptor ligands in the treatment of cardiovascular

http://www.bioportfolio.com/news/Potential_of_ghrelin_receptor_ligands_in_the.html - Monday March 1 2004

Cytokine targeting of dendritic cells to tumors produces dramatic

http://www.bioportfolio.com/news/Cytokine_targeting_of_dendritic_cells_to_tumors.html - Monday March 1 2004

New research supports switching from to exemestane after two to three

http://www.bioportfolio.com/news/New_research_supports_switching_from_to.html - Monday March 1 2004

Researchers report that controlling intracellular calcium levels may

http://www.bioportfolio.com/news/Researchers_report_that_controlling_intracellular.html - Monday March 1 2004

Researchers report the efficacy of the bisphosphonate, YM529 in

http://www.bioportfolio.com/news/Researchers_report_the_efficacy_of_the.html - Monday March 1 2004

NMDA receptor antagonism limits visceral hypersensitivity and may offer

http://www.bioportfolio.com/news/NMDA_receptor_antagonism_limits_visceral.html - Monday March 1 2004

New data published on KW-7158, a novel treatment of overactive bladder

http://www.bioportfolio.com/news/New_data_published_on_KW-7158%2C_a_novel_treatment.html - Monday March 1 2004

Merck & Co develop new leads for the treatment of bipolar disorder

http://www.bioportfolio.com/news/Merck_%26amp%3B_Co_develop_new_leads_for_the.html - Monday March 1 2004

Novo Nordisk publish data demonstrating proof of concept for potassium

http://www.bioportfolio.com/news/Novo_Nordisk_publish_data_demonstrating_proof_of.html - Saturday November 1 2003

OSI pharmaceuticals report on the pharmacokinetics, safety and efficacy

http://www.bioportfolio.com/news/OSI_pharmaceuticals_report_on_the.html - Wednesday October 1 2003

Emerging treatments for inflammatory bowel disease

http://www.bioportfolio.com/news/Emerging_treatments_for_inflammatory_bowel.html - Friday June 1 2001

Flinder Medical Centre researchers discover the cause of diabetic

http://www.bioportfolio.com/news/Flinder_Medical_Centre_researchers_discover_the.html - Friday September 1 2000

Sulfonylureas vs thiazolidinediones for the prevention of diabetic

http://www.bioportfolio.com/news/Sulfonylureas_vs_thiazolidinediones_for_the.html - Friday September 1 2000

Type 2 diabetes as a risk factor for Alzheimer's disease - defective

http://www.bioportfolio.com/news/Type_2_diabetes_as_a_risk_factor_for_Alzheimer%27s.html - Friday September 1 2000

Links between obesity/diabetes & Alzheimer disease

http://www.bioportfolio.com/news/Links_between_obesity%2Fdiabetes_%26amp%3B_Alzheimer.html - Friday September 1 2000

Incomplete control of HbA1c levels is the major drawback to current

http://www.bioportfolio.com/news/Incomplete_control_of_HbA1c_levels_is_the_major.html - Monday May 1 2000

Immunotherapeutic targeting of ovarian cancer, renal defects in diabetes,

http://www.bioportfolio.com/news/Immunotherapeutic_targeting_of_ovarian_cancer%2C.html - ?

University of Texas Medical Branch researchers publish key data on

http://www.bioportfolio.com/news/University_of_Texas_Medical_Branch_researchers.html - ?

Japanese researchers identify Interleukin-5 (IL-5) receptors as a target

http://www.bioportfolio.com/news/Japanese_researchers_identify_Interleukin-5.html - ?

Adiponectin limits tumor angiogenesis-the missing link between obesity

http://www.bioportfolio.com/news/Adiponectin_limits_tumor_angiogenesis-the_missing.html - ?

Breaking Journal Publications for the Pharmaceutical/Biotech Sector - Oct

http://www.bioportfolio.com/news/Breaking_Journal_Publications_for_the.html - ?

Boehringer Ingelheim Researchers develop new therapeutics for the

http://www.bioportfolio.com/news/Boehringer_Ingelheim_Researchers_develop_new.html - ?

DailyUpdates - breaking journal and press release articles for the drug

http://www.bioportfolio.com/news/DailyUpdates_-_breaking_journal_and_press_release.html - ?

The emerging role of the IL-4/IL-3 cytokine receptor IL-4Ralpha in asthma

http://www.bioportfolio.com/news/The_emerging_role_of_the_IL-4%2FIL-3_cytokine.html - ?

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.